These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36951564)

  • 41. Perception and willingness toward various immunization routes for COVID-19 vaccines: a cross-sectional survey in China.
    Wang H; Cui M; Li S; Wu F; Jiang S; Chen H; Yuan J; Sun C
    Front Public Health; 2023; 11():1192709. PubMed ID: 37818300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigating the tendency to use COVID-19 vaccine booster dose in Iran.
    Askarian M; Kazerooni AR; Shayan Z; Karimzadeh P; Movahedi M; Hatam N
    BMC Health Serv Res; 2023 Oct; 23(1):1051. PubMed ID: 37784095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis.
    Salman M; Mallhi TH; Khan YH; Mustafa ZU; Khan MT; Khan FU; Butt MH; Shehzadi N; Farrukh MJ; Waheed M; Azmat F; Saeed A; Mazhar SA; Ali A; Ashfaq A; Hussain K
    Hum Vaccin Immunother; 2023 Aug; 19(2):2225990. PubMed ID: 37350298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hesitancy toward COVID-19 vaccines among medical students in Southwest China: a cross-sectional study.
    Li M; Zheng Y; Luo Y; Ren J; Jiang L; Tang J; Yu X; Luo D; Fan D; Chen Y
    Hum Vaccin Immunother; 2021 Nov; 17(11):4021-4027. PubMed ID: 34357832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors Associated With the Intention to Receive the COVID-19 Vaccine: Cross-sectional National Study.
    Kasting ML; Macy JT; Grannis SJ; Wiensch AJ; Lavista Ferres JM; Dixon BE
    JMIR Public Health Surveill; 2022 Nov; 8(11):e37203. PubMed ID: 36219842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study.
    Machida M; Kikuchi H; Kojima T; Nakamura I; Saito R; Nakaya T; Hanibuchi T; Takamiya T; Odagiri Y; Fukushima N; Amagasa S; Watanabe H; Inoue S
    Hum Vaccin Immunother; 2022 Nov; 18(5):2086773. PubMed ID: 35708308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns and influencing factors of COVID-19 vaccination willingness among college students in China.
    Zhu XM; Yan W; Sun J; Liu L; Zhao YM; Zheng YB; Que JY; Sun SW; Gong YM; Zeng N; Yuan K; Shi L; Sun YK; Guo SH; Lu Y; Ran MS; Wong SYS; Shi J; Jiang ZD; Bao YP; Lu L
    Vaccine; 2022 May; 40(22):3046-3054. PubMed ID: 35450782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
    Luk TT; Zhao S; Wu Y; Wong JY; Wang MP; Lam TH
    Vaccine; 2021 Jun; 39(27):3602-3607. PubMed ID: 34034950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perceptions and Concerns Regarding COVID-19 Vaccination in a Military Base Population.
    Theis SR; Li PC; Kelly D; Ocampo T; Berglund A; Morgan D; Markert R; Fisher E; Burtson K
    Mil Med; 2022 Oct; 187(11-12):e1255-e1260. PubMed ID: 34117501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trust of Italian healthcare professionals in COVID-19 (anti-SARS-COV-2) vaccination.
    Di Valerio Z; Montalti M; Guaraldi F; Tedesco D; Nreu B; Mannucci E; Monami M; Gori D
    Ann Ig; 2022; 34(3):217-226. PubMed ID: 34328496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland.
    Rzymski P; Poniedziałek B; Fal A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: A multicenter cross-sectional study.
    Zhang L; Wu Y; Jing S; Liu X; Ren T; Liu X; Dai Z; Fu J; Chen X; Xiao W; Huang Y; Wang H; Wang W; Gu X; Ma L; Zhang S; Yu Y; Li L; Su X; Qiao Y
    Am J Infect Control; 2024 May; 52(5):525-532. PubMed ID: 38007100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China.
    Lin Y; Huang Z; Xu X; Du W; Alias H; Hu Z; Wong LP
    Hum Vaccin Immunother; 2022 Nov; 18(6):2126667. PubMed ID: 36165498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychological, social, and situational factors associated with COVID-19 vaccination intentions: A study of UK key workers and non-key workers.
    Butter S; McGlinchey E; Berry E; Armour C
    Br J Health Psychol; 2022 Feb; 27(1):13-29. PubMed ID: 33949038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preference and Willingness to Pay for the Regular COVID-19 Booster Shot in the Vietnamese Population: Theory-Driven Discrete Choice Experiment.
    Tran BX; Do AL; Boyer L; Auquier P; Le HT; Le Vu MN; Dang THT; Cao KM; Le LDT; Cu LTN; Ly BV; Nguyen DAT; Nguyen MD; Latkin CA; Ho RCM; Ho CSH; Zhang MWB
    JMIR Public Health Surveill; 2023 Jan; 9():e43055. PubMed ID: 36599156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parental coronavirus disease vaccine hesitancy for children in Bangladesh: a cross-sectional study.
    Ali M; Ahmed S; Bonna AS; Sarkar AS; Islam MA; Urmi TA; Proma TS
    F1000Res; 2022; 11():90. PubMed ID: 35211297
    [No Abstract]   [Full Text] [Related]  

  • 59. Will Africans take COVID-19 vaccination?
    Anjorin AA; Odetokun IA; Abioye AI; Elnadi H; Umoren MV; Damaris BF; Eyedo J; Umar HI; Nyandwi JB; Abdalla MM; Tijani SO; Awiagah KS; Idowu GA; Fabrice SNA; Maisara AMO; Razouqi Y; Mhgoob ZE; Parker S; Asowata OE; Adesanya IO; Obara MA; Jaumdally S; Kitema GF; Okuneye TA; Mbanzulu KM; Daitoni H; Hallie EF; Mosbah R; Fasina FO
    PLoS One; 2021; 16(12):e0260575. PubMed ID: 34851998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients.
    Zhuang W; Zhang J; Wei P; Lan Z; Chen R; Zeng C; Shi Q; Qiao G
    Hum Vaccin Immunother; 2021 Dec; 17(12):5016-5023. PubMed ID: 34715002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.